<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1466">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05142072</url>
  </required_header>
  <id_info>
    <org_study_id>DNFs</org_study_id>
    <secondary_id>Ahmed Ali</secondary_id>
    <nct_id>NCT05142072</nct_id>
  </id_info>
  <brief_title>Design and Application of Vitamin D Films for Burn Healing After Cauterizing Surgery</brief_title>
  <official_title>Formulation, Characterization and In-vivo Evaluation of Controlled Release Intranasal Films of Vitamin D3 as an Optimistic Dosage Form for Rapid and Effective Healing of Cauterized Turbinectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deraya University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Deraya University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of this method's drawbacks is the healing of cauterized cartilage after processing. It&#xD;
      was reported that the healing is so slow as no dosage form can reach this place in addition&#xD;
      to the scares produced from healing is very irritable to the patient.&#xD;
&#xD;
      From this point, the investigators start searching for a solution to this problem and reach&#xD;
      the repositioning of Vitamin D3 (calciferol) as an active ingredient for the rapidity and&#xD;
      efficacy of burn healing.&#xD;
&#xD;
      The dosage form of choice that was reported before for intranasal application by the same&#xD;
      team of investigators and gave good results. the intranasal films were proved for its&#xD;
      convince, simplicity, efficacy, and compliance to patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">December 18, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healing of cauterized tissues after surgery procedures</measure>
    <time_frame>three week</time_frame>
    <description>The outcome will be measured by endoscopic scanning pre and after application of the drug in the dosage form (representing the percent of healing) by the ENT surgeon.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patients compliance from the new dosage form</measure>
    <time_frame>three weeks</time_frame>
    <description>The patient compliance will be measured by rating the pain and the development of symptoms before surgery using a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of grades of healing by ENT surgeon</measure>
    <time_frame>three weeks</time_frame>
    <description>Evaluation of (1) bleeding (amount and frequencies), (2) crustation ( amount and nature), and (3) inflammation (size and the redness of the place of surgery)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Nasal Obstruction</condition>
  <arm_group>
    <arm_group_label>vitamin D film</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prepared intranasal films containing vitamin D3 by the investigators and administered to the right nostril with the aid of an ENT surgeon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No devices will be added</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>intranasal film</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>vitamin D film</arm_group_label>
    <other_name>Calciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients complain of nasal obstruction&#xD;
&#xD;
          -  do not respond to medications&#xD;
&#xD;
          -  treatment need surgery&#xD;
&#xD;
          -  patients accept following up in a timely manner for 3 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no nasal polyps,&#xD;
&#xD;
          -  have problems with the surgical procedures&#xD;
&#xD;
          -  have allergy with any of the treatment components (vitamin D3 or chitosan)&#xD;
&#xD;
          -  don't follow instructions or miss the following up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Minya university, faculty of medicin</name>
      <address>
        <city>Minya</city>
        <state>المنيا</state>
        <zip>05673</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 25, 2021</study_first_submitted>
  <study_first_submitted_qc>November 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Deraya University</investigator_affiliation>
    <investigator_full_name>Soad Ali</investigator_full_name>
    <investigator_title>lecturer of pharmaceutics and clinical pharmacy Deraya university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nasal Obstruction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

